Both in Pharmaceuticals
Onconetix vs Dermata Therapeutics
Over the past year ONCO returned −99.6% and DRMA returned −75.2%; their daily moves had a correlation of 0.07.
ONCO −99.6% DRMA −75.2%Growth of $1, one year, split-adjusted
| Metric | ONCO | DRMA |
|---|---|---|
| Price | $0.5690 | $0.8487 |
| Market cap | $3.3M | $4.2M |
| Today | +4.83% | +12.59% |
| 1 month | −15.5% | −23.5% |
| 6 months | −89.1% | −34.7% |
| Year to date | −99.3% | −63.4% |
| 1 year | −99.7% | −75.2% |
| Revenue growth (YoY) | −83.9% | — |
| Gross margin | 25.1% | — |
| Net margin | −16748.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.2× | — |
| Net cash | $5.8M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 157.5% | 132.3% |
| Short % of float | 7.4% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).